Perbak Capital Partners’s 3M MMM Stock Holding History

Perbak Capital Partners’s Portfolio MMM Stock Details MMM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,566	Closed	-$3.17M	–	314
2025 Q1	$3.17M	Buy	21,566 +11,886	+123%	+$1.75M	2.35%	7
2024 Q4	$1.25M	Buy	+9,680	New	+$1.27M	0.67%	39
2024 Q3	–	Sell	-103,428	Closed	-$10.6M	–	49
2024 Q2	$10.6M	Buy	+103,428	New	+$10.1M	3.13%	7

Other funds holding MMM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Perbak Capital Partners's MMM Position: Q2 2025 in Review

Perbak Capital Partners sold out of 3M (MMM) in Q2 2025, closing a stake of 21,566 shares — an estimated $3.17M sold.

Perbak Capital Partners first reported a position in MMM in Q2 2024 and held it in 3 quarters. The position peaked at $10.6M in Q2 2024. 2,141 funds tracked by Wall St. Rank hold MMM as of Q2 2025.

Perbak Capital Partners reported no remaining 3M position as of Q2 2025 after selling out during the quarter.
Perbak Capital Partners sold 21,566 3M shares in Q2 2025, an estimated $3.17M.
Perbak Capital Partners first reported a position in 3M in Q2 2024 and held it in 3 quarters.
Perbak Capital Partners's 3M position peaked at $10.6M in Q2 2024.
2,141 funds tracked by Wall St. Rank held 3M as of Q2 2025.

Based on Perbak Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.